1. Home
  2. RVLV vs BHVN Comparison

RVLV vs BHVN Comparison

Compare RVLV & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolve Group Inc.

RVLV

Revolve Group Inc.

HOLD

Current Price

$20.47

Market Cap

1.4B

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$11.26

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVLV
BHVN
Founded
2003
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
RVLV
BHVN
Price
$20.47
$11.26
Analyst Decision
Buy
Buy
Analyst Count
12
14
Target Price
$29.73
$29.08
AVG Volume (30 Days)
1.2M
2.7M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
24.64
26.08
EPS
0.20
N/A
Revenue
$1,225,682,000.00
N/A
Revenue This Year
$10.96
N/A
Revenue Next Year
$8.01
N/A
P/E Ratio
$101.75
N/A
Revenue Growth
8.48
N/A
52 Week Low
$17.35
$7.48
52 Week High
$31.68
$18.57

Technical Indicators

Market Signals
Indicator
RVLV
BHVN
Relative Strength Index (RSI) 50.92 59.09
Support Level $20.22 $10.75
Resistance Level $20.69 $11.95
Average True Range (ATR) 0.83 0.95
MACD 0.33 0.10
Stochastic Oscillator 68.92 77.03

Price Performance

Historical Comparison
RVLV
BHVN

About RVLV Revolve Group Inc.

Revolve Group Inc is an emerging e-commerce retailer, selling women's dresses, handbags, shoes, beauty products, and incidentals across its marketplace properties, Revolve and FWRD. The platform is built to suit the "next-generation customer," emphasizing mobile commerce, influencer marketing, and occupying an aspirational but attainable luxury niche. With $1.1 billion in 2024 net sales, the firm sits just outside the top 30 apparel retailers (by sales) in the U.S, but has consistently generated robust top-line growth as the industry continues to favor digital channels. Revolve generates approximately 18% of sales from private-label offerings, while focusing on building an inventory of distinctive products from emerging fashion brands with less than $10 million in annual sales.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: